BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Free Report) was the target of a large decline in short interest in the month of June. As of June 30th, there was short interest totalling 9,900 shares, a decline of 54.2% from the June 15th total of 21,600 shares. Based on an average daily volume of 26,200 shares, the days-to-cover ratio is presently 0.4 days.
BetterLife Pharma Stock Performance
Shares of OTCMKTS BETRF traded down $0.04 during midday trading on Friday, hitting $0.09. 7,000 shares of the company’s stock traded hands, compared to its average volume of 16,842. BetterLife Pharma has a 1 year low of $0.03 and a 1 year high of $0.15. The stock has a market capitalization of $10.94 million, a price-to-earnings ratio of -2.98 and a beta of 1.25. The firm has a fifty day moving average of $0.09 and a 200 day moving average of $0.08.
BetterLife Pharma (OTCMKTS:BETRF – Get Free Report) last posted its quarterly earnings data on Thursday, June 27th. The company reported ($0.01) EPS for the quarter.
About BetterLife Pharma
BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.
See Also
- Five stocks we like better than BetterLife Pharma
- What Are Dividend Challengers?
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
- Investing In Preferred Stock vs. Common Stock
- MarketBeat Week in Review – 7/8 – 7/12
- How is Compound Interest Calculated?
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
